🇺🇸 FDA
Patent

US 11041174

Compositions for linking DNA-binding domains and cleavage domains

granted A61PA61P31/00A61P35/00

Quick answer

US patent 11041174 (Compositions for linking DNA-binding domains and cleavage domains) held by Sangamo Therapeutics, Inc. expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Therapeutics, Inc.
Grant date
Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P31/00, A61P35/00, A61P43/00